Table 1 Demographic data of RTW group and non-RTW group
From: Investigation on returning to work in liver cancer survivors in Taiwan: a 5-year follow-up study
Variables | RTW (N = 1123) | Non-RTW (N = 1328) | p value |
|---|---|---|---|
Characteristic | |||
Age (years) | 50.5 ± 8.8 (23 ~ 81) | 52.7 ± 9.5 (23 ~ 85) | < 0.0001 |
Gender (male) | 874 (77.8%) | 1068 (80.4%) | 0.1146 |
Comorbidities | |||
Disorders of lipoid metabolism | 100 (8.9%) | 134 (10.1%) | 0.3196 |
Alcohol abuse | 39 (3.5%) | 31 (2.3%) | 0.0918 |
Hypertension | 230 (20.5%) | 303 (22.8%) | 0.1626 |
Congestive heart failure | 12 (1.1%) | 21 (1.6%) | 0.2724 |
Peripheral vascular disease | 8 (0.7%) | 15 (1.1%) | 0.2859 |
Cerebrovascular disease | 20 (1.8%) | 39 (2.9%) | 0.0629 |
Chronic pulmonary disease | 53 (4.7%) | 77 (5.8%) | 0.2351 |
Rheumatologic disease | 14 (1.2%) | 10 (0.8%) | 0.2162 |
Peptic ulcer disease | 178 (15.9%) | 241 (18.1%) | 0.1323 |
Mild liver disease | 704 (62.7%) | 695 (52.3%) | < 0.0001 |
Renal disease | 42 (3.7%) | 50 (3.8%) | 0.974 |
Moderate or severe liver disease | 37 (3.3%) | 38 (2.9%) | 0.5349 |
Depression | 37 (3.3%) | 37 (2.8%) | 0.4635 |
Treatment | |||
Operation | 1100 (98.0%) | 1260 (94.9%) | < 0.0001 |
Radiation therapy | 6 (0.5%) | 33 (2.5%) | 0.0001 |
Chemotherapy | 67 (6.0%) | 156 (11.7%) | < 0.0001 |
Living area when diagnosed of cancer | 0.5736 | ||
Central | 227 (20.2%) | 290 (21.8%) | |
North | 517 (46.0%) | 626 (47.1%) | |
East | 20 (1.8%) | 24 (18.2%) | |
South | 351 (31.3%) | 382 (28.8%) | |
Islands | 8 (0.7%) | 6 (0.5%) | |
Income range (TWD) | |||
< 28,800 | 658 (58.6%) | 691 (52.0%) | |
28,800–38,200 | 205 (18.3%) | 161 (12.1%) | |
> 38,200 | 260 (23.2) | 476 (35.8%) | |
Industrial classification | 0.0585 | ||
Agriculture | 97 (8.6%) | 109 (8.2%) | |
Manufacturing | 360 (32.1%) | 408 (30.7%) | |
Electricity Supply | 5 (0.4%) | 18 (1.4%) | |
Water Supply | 7 (0.6%) | 11 (0.8%) | |
Construction | 157 (14.0%) | 188 (14.2%) | |
Wholesale | 117 (10.4%) | 153 (11.5%) | |
Transportation | 111 (9.9%) | 102 (7.7%) | |
Food Service | 33 (2.9%) | 43 (3.2%) | |
Information | 22 (2.0%) | 21 (1.6%) | |
Financial | 23 (2.0%) | 28 (2.1%) | |
Real Estate | 9 (0.8%) | 22 (1.7%) | |
Technical Activities | 22 (2.0%) | 27 (2.0%) | |
Support Service | 21 (1.9%) | 41 (3.1%) | |
Public Administration | 14 (1.2%) | 25 (1.9%) | |
Education | 13 (1.2%) | 17 (1.3%) | |
Health Care | 12 (1.1%) | 22 (1.7%) | |
Other Service | 100 (8.9%) | 93 (7.0%) | |
Company size | 0.0141 | ||
Shut down | 89 (7.9%) | 152 (11.4%) | |
Small | 80 (7.1%) | 109 (8.2%) | |
Medium | 225 (20.0%) | 265 (20.0%) | |
Large | 729 (64.9%) | 802 (60.4%) | |
Pathological Tumor stage | < 0.0001 | ||
0,1 | 718 (63.9%) | 503 (37.9%) | |
2 | 276 (24.6%) | 369 (27.8%) | |
3 | 105 (9.3%) | 359 (27.0%) | |
4 | 24 (2.1%) | 97 (7.3%) | |
Pathological Node stage | < 0.0001 | ||
0 | 1117 (99.5%) | 1266 (95.3%) | |
1 | 6 (0.5%) | 62 (4.7%) | |
Pathological Metastasis stage | < 0.0001 | ||
0 | 1120 (99.7%) | 1280 (96.4%) | |
1 | 3 (0.3%) | 48 (3.6%) | |
Pathological stage | < 0.0001 | ||
0,1 | 715 (63.7%) | 495 (37.3%) | |
2 | 274 (24.4%) | 347 (26.1%) | |
3 | 131 (11.7%) | 438 (33.0%) | |
4 | 3 (0.3%) | 48 (3.6%) | |